The chemical class referred to as PCDHGC4 Inhibitors is designed to selectively modulate the activity of protocadherin gamma subfamily C member 4 (PCDHGC4). Protocadherins are a family of cell adhesion molecules known for their crucial roles in various cellular processes, particularly in neuronal development and synapse formation. PCDHGC4, as a member of the protocadherin gamma subfamily, is likely involved in mediating cell-cell interactions and facilitating the establishment and maintenance of neuronal connections. Inhibitors targeting PCDHGC4 operate by interfering with the normal functions of this protein, disrupting the intricate molecular interactions and signaling pathways in which PCDHGC4 is engaged. This interference may lead to alterations in cell adhesion patterns and could potentially impact cellular communication processes governed by PCDHGC4.
The mechanism of action for PCDHGC4 Inhibitors involves their selective binding to PCDHGC4, modulating its activity and potentially influencing downstream cellular processes. These inhibitors serve as valuable tools for researchers seeking to elucidate the specific functions of protocadherins within the broader context of cellular biology, particularly in the intricate processes of neuronal development and synaptogenesis. The study of PCDHGC4 Inhibitors, in this theoretical scenario, contributes to our understanding of the regulatory mechanisms that govern cell adhesion and communication, providing insights into the complex molecular processes involved in the formation and maintenance of neuronal networks.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Mithramycin A can bind to GC-rich sequences in DNA, possibly preventing transcription factors from binding to the PCDHGC4 promoter. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D intercalates into DNA and can inhibit RNA polymerase, which may decrease PCDHGC4 mRNA synthesis. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Triptolide has been shown to inhibit the transcription of various genes and may affect PCDHGC4 expression indirectly. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
JQ1 is a BET bromodomain inhibitor and may alter the transcription of genes by affecting the chromatin structure around PCDHGC4. | ||||||
Stat3 Inhibitor VI, S3I-201 | 501919-59-1 | sc-204304 | 10 mg | $151.00 | 104 | |
A-366 is a selective G9a/GLP histone methyltransferase inhibitor which may impact methylation status and gene expression. | ||||||
UNC0638 | 1255580-76-7 | sc-397012 | 10 mg | $315.00 | ||
UNC0638 is a potent G9a and GLP inhibitor, potentially affecting histone methylation and gene expression patterns. | ||||||
CPI-203 | 1446144-04-2 | sc-501599 | 1 mg | $170.00 | ||
CPI-455 is a KDM5 inhibitor that may lead to increased methylation of histone H3, potentially affecting PCDHGC4 transcription. | ||||||